image
Ocular Therapeutix, Inc. OCUL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.16
-7.66 %
$ 1.43 B
Market Cap
-8.4
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 13.49% -27.30% -4.74%
Annual Report FY 10-K 2022-12-31 18.32% -487.02% -0.79%
Annual Report FY 10-K 2021-12-31 150.08% 93.23% -24.17%
Annual Report FY 10-K 2020-12-31 311.71% -77.50% 26.75%
Annual Report FY 10-K 2019-12-31 112.41% -55.89% -45.14%
Annual Report FY 10-K 2018-12-31 3.48% 8.98% 4.53%
Annual Report FY 10-K 2017-12-31 1.91% -41.79% -42.92%
Annual Report FY 10-K 2016-12-31 7.83% -12.47% -13.43%
Annual Report FY 10-K 2015-12-31 126.68% -38.75% -40.98%
Annual Report FY 10-K 2014-12-31 0.00% -115.12% -109.98%
Annual Report FY 10-K 2013-12-31 0.00% 5.51% 5.62%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 2.66% -6972.29% -139.40%
Quarterly Report Q2 8-K 2024-06-30 8.26% -111.67% -111.91%
Quarterly Report Q1 8-K 2024-03-31 10.03% -78.16% -40.21%
Quarterly Report Q4 8-K 2023-12-31 5.16% -149.25% -3.55%
Quarterly Report Q3 8-K 2023-09-30 24.95% 98.08% 10.82%
Quarterly Report Q2 8-K 2023-06-30 23.81% -17.40% -3.28%
Quarterly Report Q1 8-K 2023-03-31 1.42% -401.97% -26.45%
Quarterly Report Q4 8-K 2022-12-31 14.36% -111.99% -7.28%
Quarterly Report Q3 8-K 2022-09-30 -1.55% -1009.86% -10.32%
Quarterly Report Q2 8-K 2022-06-30 4.68% -107.71% 1.56%
Quarterly Report Q1 8-K 2022-03-31 79.61% -232.33% 11.84%
Quarterly Report Q4 8-K 2021-12-31 67.48% 93.54% -25.82%
Quarterly Report Q3 8-K 2021-09-30 106.82% 122.25% -39.43%
Quarterly Report Q2 8-K 2021-06-30 646.85% 76.81% -13.12%
Quarterly Report Q1 8-K 2021-03-31 181.41% 114.51% -21.75%
Quarterly Report Q4 8-K 2020-12-31 225.75% -229.06% 32.98%
Quarterly Report Q3 8-K 2020-09-30 608.81% 36.39% 39.48%
Quarterly Report Q2 8-K 2020-06-30 141.38% -49.54% 17.20%
Quarterly Report Q1 8-K 2020-03-31 430.28% -25.62% 15.48%
Quarterly Report Q4 8-K 2019-12-31 347.62% -49.53% -23.83%
Quarterly Report Q3 8-K 2019-09-30 66.47% -25.10% -56.21%
Quarterly Report Q2 8-K 2019-06-30 0.31% -77.14% -59.24%
Quarterly Report Q1 8-K 2019-03-31 44.71% -24.40% -46.10%
Quarterly Report Q4 8-K 2018-12-31 3.49% -32.80% -35.92%
Quarterly Report Q3 8-K 2018-09-30 -4.78% 3.58% 2.50%
Quarterly Report Q2 8-K 2018-06-30 47.95% 26.16% 26.04%
Quarterly Report Q1 8-K 2018-03-31 -28.42% 14.09% 14.15%
Quarterly Report Q4 8-K 2017-12-31 -4.70% -2.18% -1.96%
Quarterly Report Q3 8-K 2017-09-30 9.64% -62.22% -64.49%
Quarterly Report Q2 8-K 2017-06-30 -0.68% -63.34% -65.11%
Quarterly Report Q1 8-K 2017-03-31 3.71% -47.81% -49.13%
Quarterly Report Q4 8-K 2016-12-31 17.20% -20.54% -21.38%
Quarterly Report Q3 8-K 2016-09-30 11.19% 16.73% 17.33%
Quarterly Report Q2 8-K 2016-06-30 -3.92% -14.35% -15.28%
Quarterly Report Q1 8-K 2016-03-31 7.51% -43.05% -47.74%
Quarterly Report Q4 8-K 2015-12-31 -13.66% -33.73% -36.15%
Quarterly Report Q3 8-K 2015-09-30 200.00% -57.99% -64.91%
Quarterly Report Q2 8-K 2015-06-30 373.20% -56.59% -62.04%
Quarterly Report Q1 8-K 2015-03-31 1477.78% -8.13% -4.22%
Quarterly Report Q4 8-K 2014-12-31 0.00% -126.93% -120.74%
Quarterly Report Q3 8-K 2014-09-30 0.00% -107.10% -97.26%
Quarterly Report Q2 8-K 2014-06-30 0.00% -106.86% -98.93%
Quarterly Report Q1 8-K 2014-03-31 0.00% -119.00% -123.04%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%